BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 26069824)

  • 1. Heparin-induced thrombocytopaenia (HIT)-an overview: what does the nephrologist need to know and do?
    Dutt T; Schulz M
    Clin Kidney J; 2013 Dec; 6(6):563-7. PubMed ID: 26069824
    [No Abstract]   [Full Text] [Related]  

  • 2. [Heparin-induced thrombocytopenia syndrome and thrombosis in patients undergoing periodic haemodialysis].
    Gregorini G; Bellandi D; Martini G; Volpi R
    G Ital Nefrol; 2002; 19(6):672-92. PubMed ID: 12508172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparin-induced thrombocytopaenia presenting as acute aortic mural thrombosis.
    Bienz MJ; Obrocki P; Russell J; Jena R; Mendichovszky IA
    BJR Case Rep; 2019 Feb; 5(1):20180025. PubMed ID: 31131116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin-induced thrombocytopaenia/thrombosis: a clinicopathologic review.
    Dave PA
    East Afr Med J; 2009 Dec; 86(12 Suppl):S62-70. PubMed ID: 21591512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparin-induced thrombocytopaenia.
    Gounden R; Blockman M
    Cardiovasc J Afr; 2008; 19(6):325-7. PubMed ID: 19104731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin-induced thrombocytopaenia complicated by arterial and venous thrombosis: report of 2 cases successfully treated by a danaparoid sodium.
    Darling K; Jaumotte C; Saussoy P; Zech F; Lavenne E; Hainaut P
    Acta Clin Belg; 2000; 55(3):176-81. PubMed ID: 10981327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody epitopes in vaccine-induced immune thrombotic thrombocytopaenia.
    Huynh A; Kelton JG; Arnold DM; Daka M; Nazy I
    Nature; 2021 Aug; 596(7873):565-569. PubMed ID: 34233346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparin-induced thrombocytopaenia diagnostic testing after adult cardiac surgery: a single-centre experience and development.
    Schaefer AK; Donhauser B; Kroeckel I; Füreder L; Holaubek C; Braunschmid T; Mouhieddine M; Panzer S; Dworschak M; Steinlechner B
    Eur J Cardiothorac Surg; 2019 Apr; 55(4):722-728. PubMed ID: 30395203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review: anticoagulation for haemodialysis.
    Suranyi M; Chow JS
    Nephrology (Carlton); 2010 Jun; 15(4):386-92. PubMed ID: 20609088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A combined approach to treat heparin-induced thrombocytopaenia before heart transplant.
    Sandoval E; Lozano M; Pereda D; Quintana E; Cid J; García-Álvarez A; Fernández-Cisneros A; Castellá M
    Interact Cardiovasc Thorac Surg; 2020 Dec; 31(6):881-883. PubMed ID: 33155030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin-induced thrombocytopaenia.
    Prince M; Wenham T
    Postgrad Med J; 2018 Aug; 94(1114):453-457. PubMed ID: 30126928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticoagulation with r-hirudin in regular haemodialysis with heparin-induced thrombocytopenia (HIT II). The first long-term application of r-hirudin in a haemodialysis patient.
    Nowak G; Bucha E; Brauns I; Czerwinski R
    Wien Klin Wochenschr; 1997 May; 109(10):354-8. PubMed ID: 9200807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bilateral adrenal haemorrhage: a cause of haemodynamic collapse in heparin-induced thrombocytopaenia.
    Saleem N; Khan M; Parveen S; Balavenkatraman A
    BMJ Case Rep; 2016 Mar; 2016():. PubMed ID: 26965409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. National survey of heparin-induced thrombocytopenia in the haemodialysis population of the UK population.
    Hutchison CA; Dasgupta I
    Nephrol Dial Transplant; 2007 Jun; 22(6):1680-4. PubMed ID: 17371779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving compliance with appropriateness of testing for heparin-induced thrombocytopaenia: a quality improvement report.
    Mericliler M; Kazakova V; Nicolas D; Acharya UH; Jaber BL
    BMJ Open Qual; 2022 Jul; 11(3):. PubMed ID: 35820712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel method for the management of patients with heparin-induced thrombocytopaenia during cardiac surgery.
    Mishra PK; Chnaris A; Mohammed F; Luckraz H
    Interact Cardiovasc Thorac Surg; 2014 Jun; 18(6):850-2. PubMed ID: 24608730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective randomised open-label comparison of danaparoid with dextran 70 in the treatment of heparin-induced thrombocytopaenia with thrombosis: a clinical outcome study.
    Chong BH; Gallus AS; Cade JF; Magnani H; Manoharan A; Oldmeadow M; Arthur C; Rickard K; Gallo J; Lloyd J; Seshadri P; Chesterman CN;
    Thromb Haemost; 2001 Nov; 86(5):1170-5. PubMed ID: 11816702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac surgery and heparin induced thrombocytopaenia (HIT): a case report and short review.
    McMeniman WJ; Chard RB; Norrie J; Posen J
    Heart Lung Circ; 2012 May; 21(5):295-9. PubMed ID: 22459238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenetics to prevent heparin-induced thrombocytopenia: what do we know?
    Karnes JH
    Pharmacogenomics; 2018 Dec; 19(18):1413-1422. PubMed ID: 30398086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GFHT proposals on the practical use of argatroban - With specifics regarding vaccine-induced immune thrombotic thrombocytopaenia (VITT).
    Siguret V; Boissier E; De Maistre E; Gouin-Thibault I; James C; Lasne D; Mouton C; Godon A; Nguyen P; Lecompte T;
    Anaesth Crit Care Pain Med; 2021 Dec; 40(6):100963. PubMed ID: 34673303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.